Phase 1 Lung Neoplasms Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1

Anti-Mesothelin TNaive/SCM hYP218 (TNhYP218) CAR T Cells in Participants With Mesothelin-Expressing Solid Tumors Including Mesothelioma

Ovarian NeoplasmsStomach NeoplasmsLung Neoplasms+5 more

National Cancer Institute (NCI)100 enrolled1 locationNCT06885697

Recruiting

Phase 1

Phase I Study of JYP0322 in ROS1 Fusion-Positive Solid Tumors

Lung NeoplasmsBrain NeoplasmsProtein Kinase Inhibitors+1 more

Guangzhou JOYO Pharma Co., Ltd101 enrolled1 locationNCT06128148

Recruiting

Phase 1Phase 2

HTL0039732 in Participants With Advanced Solid Tumours

SarcomaUrinary Bladder NeoplasmsUterine Cervical Neoplasms+11 more

Cancer Research UK150 enrolled5 locationsNCT05944237